Physician profile
Eugene Tsai
NPI 1922006378
$9,292.73
in general payments reported to CMS, 2019-2025
9 companies · $163 in 2025
The $163 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $391 · 2020: $17.18 · 2021: $180 · 2022: $175 · 2023: $234 · 2024: $8,132 · 2025: $163.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $7,200 · Travel and Lodging: $932 · Food and Beverage: $398.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $7,200.00 |
| Travel and Lodging | $931.56 |
| Food and Beverage | $397.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Skeletal Dynamics INC | $8,131.56 | 2024 | Ijs, Geminus, Align |
| Musculoskeletal Transplant Foundation INC. | $454.85 | 2019-2021 | |
| Integra Lifesciences Corporation | $175.05 | 2022 | |
| Bioventus LLC | $163.18 | 2025 | Exogen Ultrasound Bone Healing System |
| Saxum Surgical, INC. | $151.89 | 2023 | |
| Zimmer Biomet Holdings, INC. | $116.59 | 2019 | |
| Endo Pharmaceuticals INC. | $47.93 | 2023 | Xiaflex |
| Acumed LLC | $34.50 | 2023 | Inframe Implant, Innate Implant |
| Micromed INC | $17.18 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eugene Tsai listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.